Prelude Therapeutics
PRLD
#9029
Rank
A$0.10 B
Marketcap
$1.93
Share price
6.72%
Change (1 day)
-57.40%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -$3.26

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.27. In 2022 the company made an earnings per share (EPS) of -$3.68 a decrease over its 2021 EPS that were of -$3.65.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.26-11.31%
2022-$3.680.83%
2021-$3.65-61.3%
2020-$9.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.29 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA